| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/02/1997 | WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 10/02/1997 | WO1997035958A1 Storage articles for prolonged viability and function of living cells |
| 10/02/1997 | WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 10/02/1997 | WO1997035596A1 Method and formula for the prevention of diarrhea |
| 10/02/1997 | WO1997035595A1 Egg anti-inflammatory composition, method of isolation and use |
| 10/02/1997 | WO1997035594A1 Linseed drug |
| 10/02/1997 | WO1997035558A1 Remedy for external application, and use of an oil-in-water emulsion for said remedy |
| 10/02/1997 | WO1997035490A1 Colostrum food supplement |
| 10/02/1997 | WO1997028812A3 Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre) |
| 10/02/1997 | WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip) |
| 10/02/1997 | DE19611969A1 Use of antifreeze peptide in transfusion medicine |
| 10/02/1997 | CA2250332A1 Antitumour cellular compositions expressing at least three transgenes |
| 10/02/1997 | CA2250211A1 Colostrum food supplement |
| 10/02/1997 | CA2250173A1 Cytochrome p450 transducing retroviral vectors |
| 10/02/1997 | CA2250099A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 10/02/1997 | CA2250058A1 Recombinant pox virus encoding myelin protein for therapy |
| 10/02/1997 | CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 10/01/1997 | EP0798375A2 Human lens epithelial cell line |
| 10/01/1997 | EP0798374A1 Method for in vitro production of bone |
| 10/01/1997 | EP0798001A2 Collagen containing preparations for strengthening bone |
| 10/01/1997 | EP0797678A2 Hybrid adenovirus-aav virus and method of use thereof |
| 10/01/1997 | EP0797676A2 Recombinant adenoviral vector and methods of use |
| 10/01/1997 | EP0797455A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
| 10/01/1997 | EP0797454A1 Improved adenoviral vectors and producer cells |
| 10/01/1997 | EP0797450A1 In vitro t-lymphopoiesis system |
| 10/01/1997 | EP0797446A1 Cd40 associated proteins |
| 10/01/1997 | EP0728193A4 Method for mammalian cell separation from a mixture of cell populations |
| 10/01/1997 | EP0722331A4 Method for producing a highly enriched population of hematopoietic stem cells |
| 10/01/1997 | CN1160706A Extraction method of unsaturated fatty acid from fish oil |
| 10/01/1997 | CN1160570A Burns curing cream and its preparation |
| 10/01/1997 | CN1160566A Guyinggao ointment |
| 10/01/1997 | CN1160558A Burns curing powder and its preparation |
| 10/01/1997 | CN1160554A Marmot bone wine for curing rheumatism |
| 10/01/1997 | CN1160553A Marmot oil ointment for burns and scald |
| 10/01/1997 | CN1160548A Process for producing Qingkailing powder injection |
| 10/01/1997 | CN1160543A Marmot oil ointment for tinea pedis, tinea manuum, beriberi and smelly foot |
| 10/01/1997 | CN1160542A Liquid crocodile composite and its preparation |
| 10/01/1997 | CN1160541A Externally applied drug for wet beriberi and its preparation process |
| 09/30/1997 | US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins |
| 09/30/1997 | US5672361 Laminin 5 for growth of pancreatic islet cells |
| 09/30/1997 | US5672346 Human stem cell compositions and methods |
| 09/30/1997 | US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected |
| 09/29/1997 | CA2201216A1 Human lens epithelial cell line |
| 09/25/1997 | WO1997035024A1 Enzyme combinations for destroying proliferative cells |
| 09/25/1997 | WO1997035021A2 Prostate specific antigen oligo-epitope peptide |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997035004A1 Cell stimulation |
| 09/25/1997 | WO1997034628A1 Milk of transgenic animals containing human alpha1-antitrypsin and use of human alpha1-antitrypsin to treat bile acid related diseases |
| 09/25/1997 | WO1997034624A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | WO1997034619A1 Methods of treating herpes or chlamydia |
| 09/25/1997 | WO1997034615A1 Enhancement of microbial colonisation of the gastrointestinal tract |
| 09/25/1997 | WO1997034614A1 Process for the preparation of platelet growth factors extract for wound healing compositions |
| 09/25/1997 | WO1997034591A1 Alteration of microbial populations in the gastrointestinal tract |
| 09/25/1997 | WO1997034472A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | DE19634159C1 Hybrid cells prepared by fusing malignant B cells with hybridoma that expresses antibodies |
| 09/25/1997 | CA2249534A1 Process for the preparation of platelet growth factors extract for wound healing compositions |
| 09/25/1997 | CA2249412A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | CA2249196A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2249189A1 Alteration of microbial populations in the gastrointestinal tract |
| 09/25/1997 | CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | CA2248629A1 Enzymes combinations for destroying proliferative cells |
| 09/24/1997 | EP0796338A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 09/24/1997 | EP0796332A1 Neisseria meningitidis subunit tbp2 |
| 09/24/1997 | EP0796320A1 Human dna ligase iii |
| 09/24/1997 | EP0796275A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 09/24/1997 | EP0796110A2 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 09/24/1997 | EP0796107A1 Sunscreen-wound healing composition |
| 09/24/1997 | EP0796102A1 A composition for treating endometriosis, containing a precious metal salt and a natural sweetening agent |
| 09/24/1997 | EP0796094A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 09/24/1997 | EP0796040A1 Method and bag set for concentrating white cells |
| 09/24/1997 | EP0696933A4 Composition and method for enrichment of white blood cells from whole human blood |
| 09/24/1997 | CN1159946A 冬莲强肝丸 Dong Lin Qianggan pill |
| 09/24/1997 | CN1159945A 丹藤治栓丸 Tando rule bolt pill |
| 09/24/1997 | CN1159944A 九龙接骨丸 Kowloon bone pill |
| 09/24/1997 | CN1159943A Medicine for treatment of thromboangiitis obliterans |
| 09/24/1997 | CN1159942A Placenta tonic and its processing and use |
| 09/24/1997 | CN1159934A Wind-expelling and pain-alleviating drug for external use |
| 09/24/1997 | CN1159931A Anti-inflammatory and analgesic capsule |
| 09/24/1997 | CN1159919A Senility-proof health medicine |
| 09/24/1997 | CN1159918A Method for preparing anticancer bioactive peptide preparation |
| 09/23/1997 | US5670361 HIV-specific ribozymes |
| 09/23/1997 | US5670175 Process for obtaining ultrapure egg oil and its use |
| 09/23/1997 | US5670148 Combined cellular and immunosuppressive therapies |
| 09/23/1997 | US5670060 Method for treating a biological fluid including transition zone material |
| 09/18/1997 | WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033991A1 Short external guide sequences |
| 09/18/1997 | WO1997033978A1 Hematopoietic cell culture nutrient supplement |
| 09/18/1997 | WO1997033614A1 Use of coxiella bacteria to treat autoimmune disease |
| 09/18/1997 | WO1997033594A1 Methods of using emu oil and active fractions thereof as an insect repellent |
| 09/18/1997 | WO1997033593A1 A product of heat treatment of uronic acid, food, drink or drug including the product |
| 09/18/1997 | WO1997033549A1 A hygienic bag and preparation thereof |
| 09/18/1997 | WO1997033487A1 Oral composition for animals |
| 09/18/1997 | WO1997033470A1 Method and media for enhancing viability, maturation, and cryopreservation of cells |
| 09/18/1997 | WO1997020569A3 Bioartificial devices and cellular matrices therefor |
| 09/18/1997 | DE19647352C1 Non-alcoholic clear drinks such as table water and mineral water |
| 09/18/1997 | DE19549420A1 Tumour necrosis factor-alpha and/or bacterial lipo-poly:saccharide removal |